Skip to content
Neuronet
Neuronet - The support action for EU research on neurodegeneration
  • ABOUT
        • Objectives
        • Glossary
        • Work Packages
        • Partners
        • Executive Committee
        • Task Forces
        • Working Groups
        • Scientific Coordination Board
  • EVENTS
        • 2021: Virtual event
        • 2020: Virtual Event
        • 2019: The Hague
        • Event Calendar
  • NEWS
        • Latest news
        • Neuronet newsletters
        • Neuronet in the Media
  • PROJECTS
        • Ongoing Projects
        • Completed Projects
        • Project Overview
        • Project Timescales
  • RESOURCES
        • Asset Map
        • Project Tools
        • Regulatory & HTA Decision Tool
        • Neuronet Tools
        • Neuronet Deliverables
        • Neuronet Presentations
        • Publications
        • Useful resources for young researchers
  • KNOWLEDGE BASE

ROADMAP

Neuronet publishes series of project introduction videos during Brain Awareness Week

20th April 202214th March 2022

The Neuronet programme launched a series of short introduction videos of the various Innovative Medicines

Neuronet convenes annual event on European research collaboration in Alzheimer’s disease & beyond

22nd December 2021

Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together

Conducting public involvement in dementia research

23rd November 2021
15 ROADMAP

Dementia outcomes include memory loss, language impairment, reduced quality of life and personality changes. Research

Neuronet launches its social media campaign “Programme impact analysis – where we are and where we need to go”

16th November 20218th November 2021
IMI nd projects social media campaign

The Neuronet project is setting up an efficient platform to boost collaboration across research projects

Neuronet convenes 7th meeting of its Scientific Coordination Board

10th January 202222nd October 2021
SCB update

On 21 October, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened

3-dimensional representation of European data availability landscape for Alzheimer’s disease research

6th October 20216th October 2021
This Cube offers a dynamic overview of the 'landscape' of data availability in Europe for Alzheimer's disease (AD) research

The Real world Outcomes across the Alzheimer’s Disease spectrum for better care: Multi-modal data Access

Neuronet says farewell to Diana O’Rourke and welcomes Fatima Salih to the team

26th September 2021
Neuronet logo - The support action for EU research on neurodegeneration holds meeting on key assets

On 26 September 2021, Diana O’Rourke left her position as Senior Analyst at the National

The Innovative Medicines Initiative’s impact on dementia – presentations online!

20th September 202121st June 2021
IMI IMPACT SERIES

The Innovative Medicines Initiative (IMI) organised a series of online live sessions on its impact.

Communication representatives of neurodegeneration research projects exchange on best practices

3rd March 202219th May 2021
Innovative Medicines Initiative projects on neurodegeneration

On 7 May, representatives of 12 Innovative Medicines Initiative neurodegeneration research projects met virtually to

Alzheimer’s disease treatments: The Need for a Holistic Approach

28th April 202118th March 2021

As part of the latest digital supplement to Value & Outcomes Spotlight, the International Society

Post navigation
Older posts
Page1 Page2 Page3 Next →

LATEST NEWS

  • Neuronet publishes Frontiers in Neurology article, analysing the structure, assets and collaborative networks in the IMI neurodegeneration portfolio

    9th November 2022
    The Innovative Medicines Initiative (IMI) was launched in 2008, with an initial budget of €8bn.Read More
  • Spotlight on Early-Career researchers a Neuronet interview with Ilja Saris

    5th September 2022
    In this Neuronet spotlight on early-career researcher interview, we speak with Ilja Saris who worksRead More
  • Spotlight on Communication experts: A Neuronet Blog with Cindy Birck

    29th August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
  • Webinar series: Mobilise-D presents its four patient cohorts

    25th August 2022
    Mobilise-D starts the autumn webinar series presenting the needs, technologies, protocols and user perspectives forRead More
  • Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus

    23rd August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More

Neuronet

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any information on this website solely reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

 

Innovative Medicines InitiativeEU Flag logoEuropean Federation of Pharmaceutical Industries and Associations logoParksinson's UK logo

Disclaimer
About IMI
Legal notice
Privacy policy

@ 2019 – IMI-NEURONET

© 2023 - IMI-NEURONET
We use cookies to offer you a better browsing experience and to analyze site traffic. Read about how we use cookies and how you can control them in our Cookie Policy. If you continue to use this site, you consent to our use of cookies. AcceptCookie policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT